Clinical utility of monitoring sialyl Lewis(x) (CD15s) antigen on peripheral lymphocytes for the diagnosis and treatment of rejection after renal transplantation

Transplant Proc. 2000 Mar;32(2):265-8. doi: 10.1016/s0041-1345(99)00952-5.

Authors

H Ishida¹, I Koyama, T Sawada, T Murakami, K Utsumi, A Sannomiya, K Tsuji, T Tojimbara, I Nakajima, K Tanabe, S Fuchinoue, Y Yamaguchi, H Toma, T Agishi

Affiliation

¹ Department of Surgery III, Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.

PMID: 10715412
DOI: 10.1016/s0041-1345(99)00952-5

No abstract available

MeSH terms

Adult
Female
Flow Cytometry
Graft Rejection / diagnosis*
Graft Rejection / drug therapy*
Graft Rejection / pathology
Humans
Kidney Transplantation / immunology*
Kidney Transplantation / pathology
Lewis Blood Group Antigens
Lymphocytes / immunology
Male
Monitoring, Immunologic*
Oligosaccharides / blood*
Postoperative Complications / blood
Postoperative Complications / immunology
Sialyl Lewis X Antigen

Substances

Lewis Blood Group Antigens
Oligosaccharides
Sialyl Lewis X Antigen